Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to... see more

OTCPK:MEDVF - Post Discussion

Medivolve Inc > Wouldn't sell my shares to
View:
Post by Patienceiskee on Oct 21, 2021 12:39pm

Wouldn't sell my shares to

To you or anyone for $0.04 for $0.05 no nothing less of $1 I'll wait I'm a patient person I usually go where I think the herd will be go. So anybody that wants to sell sell their shares for a penny or two then go f*** themselves. There I had my rent for the morning but feel better now
Comment by knowsbest on Oct 21, 2021 1:10pm
You can do this every day..sustanable for a long time 
Comment by Frosted on Oct 21, 2021 9:34pm
Yes. But the herd for the most part is heading for the exits while yu go the other way. Just sayin.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities